CERS 10 Year Annualized Return and Average Annual Return

The CERS 10 year annualized return is -6.52% with dividends reinvested through 07/16/2026. Investors often use annualized return to compare long-term performance because it shows the average yearly compounded return over a full period rather than just the headline total gain.

This page shows CERS average annual return, total return, start and end dates, and the growth of a hypothetical $10,000 investment with dividends reinvested.

Quick links: Annualized Return Table  |  Performance Chart  |  FAQ
CERS Average Annual Return Chart 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into CERS

Also see:
• CERS stock yearly return 2016
• CERS stock yearly return 2017
• CERS stock yearly return 2018
• CERS stock yearly return 2019
• CERS stock yearly return 2020
• CERS stock yearly return 2021
• CERS stock yearly return 2022
• CERS stock yearly return 2023
• CERS stock yearly return 2024
• CERS stock yearly return 2025
• CERS YTD return
Average Annual Return Benchmarks
Compare CERS average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
CERS Share Performance
CERS Average Annual Return Table 10 Years
Start date: 07/19/2016
End date: 07/16/2026
Start price/share: $6.30
End price/share: $3.21
Dividends collected/share: $0.00
Total return: -49.05%
CERS Average Annual Return: -6.52%
Starting investment: $10,000.00
Ending investment: $5,096.44
Years: 10.00


CERS average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Cerus Corp.
Cerus Corporation is a biomedical products company. Co. is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The CERS average annual return 10 years is shown above.

The Average Annual Return on the CERS average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether CERS average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CERS average annual return calculation with any dividends reinvested as applicable (on ex-dates).
CERS Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree CERS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Cerus (CERS) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

CGEM Average Annual Return
CGEN Average Annual Return
CGON Average Annual Return
CGTX Average Annual Return
CHE Average Annual Return
CHRS Average Annual Return
CI Average Annual Return
CING Average Annual Return
CLDX Average Annual Return
CLNN Average Annual Return
More Healthcare companies »
What has the average annual return been for CERS over the past ten years?
✔️Accepted answer: The ten year CERS average annual return has been -6.52%.

What start date was used in your CERS average annual return calculation?
✔️Accepted answer: The start date was 07/19/2016.

What end date was used in your CERS average annual return calculation?
✔️Accepted answer: The end date was 07/16/2026.

If I had invested $10,000 into CERS ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 07/16/2026, you would have $5,096.44.

What does that work out to on a total return basis?
✔️Accepted answer: The CERS ten year total return ending 07/16/2026 works out to -49.05%.


Also see:
• CERS stock yearly return 2016
• CERS stock yearly return 2017
• CERS stock yearly return 2018
• CERS stock yearly return 2019
• CERS stock yearly return 2020
• CERS stock yearly return 2021
• CERS stock yearly return 2022
• CERS stock yearly return 2023
• CERS stock yearly return 2024
• CERS stock yearly return 2025
• CERS YTD return
 

CERS 10 Year Annualized Return & Average Annual Return | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.